volume 69 pages 131-138

A current view on Tau protein phosphorylation in Alzheimer's disease

Publication typeJournal Article
Publication date2021-08-01
scimago Q1
wos Q1
SJR2.540
CiteScore10.9
Impact factor5.2
ISSN09594388, 18736882
General Neuroscience
Abstract
The functions of the neuronal microtubule-associated protein Tau in the central nervous system are regulated by manifold posttranslational modifications at more than 50 sites. Tau in healthy neurons carries multiple phosphate groups, mostly in its microtubule assembly domain. Elevated phosphorylation and aggregation of Tau are widely considered pathological hallmarks in Alzheimer's disease (AD) and other tauopathies, triggering the quest for Tau posttranslational modifications in the disease context. However, the phosphorylation patterns of physiological and pathological Tau are surprisingly similar and heterogenous, making it difficult to identify specific modifications as therapeutic targets and biomarkers for AD. We present a concise summary of - and view on - important previous and recent advances in Tau phosphorylation analysis in the context of AD.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
16
International Journal of Molecular Sciences
15 publications, 4.32%
Frontiers in Aging Neuroscience
9 publications, 2.59%
Journal of Alzheimer's Disease
7 publications, 2.02%
Ageing Research Reviews
5 publications, 1.44%
Brain Research Bulletin
5 publications, 1.44%
Biomedicine and Pharmacotherapy
5 publications, 1.44%
Neurobiology of Disease
5 publications, 1.44%
bioRxiv
5 publications, 1.44%
Molecular Neurobiology
4 publications, 1.15%
Metabolic Brain Disease
4 publications, 1.15%
Neural Regeneration Research
4 publications, 1.15%
Frontiers in Pharmacology
4 publications, 1.15%
Biomolecules
3 publications, 0.86%
Biology
3 publications, 0.86%
Cells
3 publications, 0.86%
Frontiers in Cellular Neuroscience
3 publications, 0.86%
Journal of Biological Chemistry
3 publications, 0.86%
Neuroscience
3 publications, 0.86%
Journal of Proteome Research
3 publications, 0.86%
Journal of Neurochemistry
3 publications, 0.86%
Journal of Biomolecular Structure and Dynamics
3 publications, 0.86%
Methods in Molecular Biology
3 publications, 0.86%
Pharmaceuticals
3 publications, 0.86%
Biomedicines
3 publications, 0.86%
European Journal of Pharmacology
3 publications, 0.86%
Molecular Biology Reports
3 publications, 0.86%
Advances in Protein Chemistry and Structural Biology
3 publications, 0.86%
CNS Neuroscience and Therapeutics
3 publications, 0.86%
Frontiers in Neurology
3 publications, 0.86%
2
4
6
8
10
12
14
16

Publishers

10
20
30
40
50
60
70
80
90
Elsevier
90 publications, 25.94%
Springer Nature
52 publications, 14.99%
MDPI
46 publications, 13.26%
Wiley
31 publications, 8.93%
Cold Spring Harbor Laboratory
27 publications, 7.78%
Frontiers Media S.A.
25 publications, 7.2%
American Chemical Society (ACS)
12 publications, 3.46%
SAGE
9 publications, 2.59%
Taylor & Francis
7 publications, 2.02%
Bentham Science Publishers Ltd.
5 publications, 1.44%
Oxford University Press
5 publications, 1.44%
American Society for Biochemistry and Molecular Biology
3 publications, 0.86%
American Medical Association (AMA)
2 publications, 0.58%
Royal Society of Chemistry (RSC)
2 publications, 0.58%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 0.58%
Pleiades Publishing
2 publications, 0.58%
Medknow
2 publications, 0.58%
The Company of Biologists
1 publication, 0.29%
Hindawi Limited
1 publication, 0.29%
Institute of Cytology and Genetics SB RAS
1 publication, 0.29%
Annual Reviews
1 publication, 0.29%
Research Square Platform LLC
1 publication, 0.29%
OAE Publishing Inc.
1 publication, 0.29%
The Endocrine Society
1 publication, 0.29%
Akademizdatcenter Nauka
1 publication, 0.29%
EDP Sciences
1 publication, 0.29%
Impact Journals
1 publication, 0.29%
Science Alert
1 publication, 0.29%
A and V Publications
1 publication, 0.29%
10
20
30
40
50
60
70
80
90
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
348
Share
Cite this
GOST |
Cite this
GOST Copy
Wegmann S. et al. A current view on Tau protein phosphorylation in Alzheimer's disease // Current Opinion in Neurobiology. 2021. Vol. 69. pp. 131-138.
GOST all authors (up to 50) Copy
Wegmann S., Biernat J., Mandelkow E. A current view on Tau protein phosphorylation in Alzheimer's disease // Current Opinion in Neurobiology. 2021. Vol. 69. pp. 131-138.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.conb.2021.03.003
UR - https://doi.org/10.1016/j.conb.2021.03.003
TI - A current view on Tau protein phosphorylation in Alzheimer's disease
T2 - Current Opinion in Neurobiology
AU - Wegmann, Susanne
AU - Biernat, Jacek
AU - Mandelkow, E.-M.
PY - 2021
DA - 2021/08/01
PB - Elsevier
SP - 131-138
VL - 69
PMID - 33892381
SN - 0959-4388
SN - 1873-6882
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Wegmann,
author = {Susanne Wegmann and Jacek Biernat and E.-M. Mandelkow},
title = {A current view on Tau protein phosphorylation in Alzheimer's disease},
journal = {Current Opinion in Neurobiology},
year = {2021},
volume = {69},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016/j.conb.2021.03.003},
pages = {131--138},
doi = {10.1016/j.conb.2021.03.003}
}